Hyun Ji Hwang

Disclosure information not submitted.

Presentation(s):

• PD43-02: Therapeutic efficacy of YM155 to repress an epigenetic enzyme and everolimus resistance in RCC.

  Sunday, May 15, 2022
  9:40 AM – 9:50 AM